Oscar Caipo ری ٹویٹ کیا

The first trial of creatine in Alzheimer’s disease was just published and the results are big.
Patients took 20 grams of creatine monohydrate daily for 8 weeks.
Brain creatine levels rose 11%, and cognition significantly improved across multiple domains, including memory, reading, and attention.
Nearly every participant stuck with the protocol. No drug, no major side effects.
Caveat: it was a small, single-arm pilot study with no placebo group, so results must be interpreted cautiously.
Still, encouraging signs from a humble supplement.

English

















